American Biogenetics acquires Stellar :
This article was originally published in Clinica
Executive Summary
American Biogenetic Sciences has bought Stellar Bio Systems in a staged payment deal that could total around $1.4 million in stock and cash. According to ABS, the acquisition will bring it access to new distribution channels for ABS' Thrombus Precursor Protein (tpP) and Functional Intact Fibrinogen (FiF) diagnostic tests. It will also provide its own immunodiagnostic test menu and Antigen Free technology, to produce monoclonal antibodies unattainable by conventional means. ABS will make an initial payment of $700,000 in stock and $120,000 in cash with milestone payments over the next three years.
You may also be interested in...
EWG Study Suggests More Than One In 10 Talc-Based Cosmetics Contain Asbestos
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
Hair Supplement Linked To Cases Of Severe Hepatitis In France
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: